Get the Stockscreener App
8.14
9.56%
-0.86
After Hours:
8.34
0.20
+2.46%
Recursion Pharmaceuticals Inc Stock (RXRX) Latest News
Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA's AI Favorite? - MSN
Top Biotech Stocks To ConsiderFebruary 20th - MarketBeat
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - AOL
Recursion to Report Fourth Quarter and Fiscal Year 2024 Business Updates and Financial Results on February 28th - The Manila Times
Recursion Pharmaceuticals, Inc. (RXRX): The Best Performing Pharma Stock So Far in 2025? - Insider Monkey
(RXRX) Trading Signals - Stock Traders Daily
10 Best Performing Pharma Stocks So Far in 2025 - Insider Monkey
Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA’s AI Favorite? - MarketBeat
Cathie Wood Explains Why She Likes Recursion Pharmaceuticals, Inc. (RXRX) - MSN
Recursion Pharma Accelerator Steps In to Fill Some of the Funding Gap Amid NIH Tumult - Dealbreaker
Biotech Stocks Worth WatchingFebruary 15th - MarketBeat
Why Recursion Pharmaceuticals, Inc. (RXRX) is the Best Performing Healthcare Stock So Far in 2025 - MSN
Backed by Recursion CEO, Altitude Lab venture aims to fill gap from NIH cuts - MM+M Online
10 Best Performing Healthcare Stocks So Far in 2025 - Insider Monkey
Recursion CEO launches pre-seed fund in response to NIH cuts - BioPharma Dive
Why Jensen Huang’s Company Is Betting On Recursion Pharmaceuticals, Inc. (RXRX) - MSN
Altitude Lab Launches Pre-seed Venture Fund, Anchored by Recursion CEO Chris Gibson, Enabling SBIR-awarded Biotechs Hit by Funding Gap to Build in Salt Lake City - The Manila Times
Can This New Biotech Fund Save 1,500 Startups Hit by SBIR Changes? - StockTitan
Could this Nvidia-backed growth stock be a millionaire-maker at $10? - Yahoo Finance UK
Recursion CEO: Publicly funded research built the biopharma industry. Now it needs our help - STAT
Why Recursion Pharmaceuticals, Inc. (RXRX) Soared on Wednesday - MSN
Recursion Pharmaceuticals Stock Scores RS Ratings Over 90 - MSN
5 Stocks Jensen Huang’s Company is Betting On - Insider Monkey
Recursion Pharmaceuticals Before Q4 Earnings: How to Play the Stock - MSN
Altitude Lab's Startup Portfolio Hits $154M Milestone: Inside the Biotech Incubator's Success Story - StockTitan
25 Top AI Stocks That Could Boost Your Portfolio - The Motley Fool
SoftBank Joins Nvidia In Backing Recursion Pharma, Retail Traders Rally Behind Stock Surge - NewsBreak
Nvidia-Backed Recursion Pharma Hits 3-Week High, Sparks Retail Buzz Amid Broader AI Hype - MSN
Best Biotech Stocks To Keep An Eye OnFebruary 14th - MarketBeat
Promising Mid Cap Stocks To Add to Your WatchlistFebruary 16th - MarketBeat
The Rise of Recursion Pharmaceuticals: A Biotech Stock on the Move - RagingBull
Promising Biotech Stocks To Follow NowFebruary 17th - MarketBeat
Why Recursion Pharmaceuticals, Inc. (RXRX) Soared Last Week - MSN
SoftBank reports new stakes in PacBio, Recursion Pharmaceuticals - MSN
Recursion Pharmaceuticals (NASDAQ: RXRX) Surges Nearly 24% as Nvidia Retains Stake – market - HPBL
Recursion Pharmaceuticals Stock Soars as Nvidia Maintains Stake – A Vote of Confidence? – market - HPBL
Recursion Pharmaceuticals (RXRX) Sees Institutional Investors Adjust Positions Amid Market Volatility - HPBL
Institutional Investors Bet Big on Recursion Pharmaceuticals (RXRX) Amid Growing Biotech Interest - HPBL
Why Recursion Pharmaceuticals (RXRX) Skyrocketed 23.88% on Friday – market - HPBL
Recursion Pharmaceuticals (RXRX): A Biotech Stock Outpacing the Market with Explosive Growth - HPBL
Recursion Pharmaceuticals (RXRX) Stock Surges 15%: Nvidia’s Vote of Confidence Sparks AI Biotech Rally - HPBL
Recursion Pharmaceuticals Stock Surges 15.8% as Nvidia Retains Stake – market - HPBL
Mirae Asset Global Investments Co. Ltd. Sells 74,818 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - MarketBeat
Shares of 10 Firms Soar on Friday - Insider Monkey
Why Recursion Pharmaceuticals Inc. (RXRX) Soared on Friday? - Insider Monkey
0.53%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):